Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Svennilson Peter
Relationship:   Director, 10% Owner
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   21,988,435    

Indirect Shares

   28,546,447      
Direct Value   $116,391,392    

Indirect Value

   $278,020,308      
Total Shares   50,534,882      
Total Value   $394,411,700      


Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $825,885 Nurix Therapeutics, Inc. $0 Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $825,885 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    32   
    4    

     Stock price went up :
    32   
    1    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   32.0   
   32.0   
     Percentage Gain/Loss :
   66.6%
 -51.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ Managing Partner, 10% ... 2019-04-02 0 2017-10-27 6,642,942    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2021-02-17 2,584,957 2021-02-17 3,645,681    Premium*  
            Gritstone Oncology, Inc. GRTS Director, 10% Owner 2018-10-02 0 2018-10-02 3,102,934    Premium*  
            Ngm Biopharmaceuticals Inc NGM Managing Partner, 10% ... 2020-08-28 17,988,843 2020-08-28 190,000    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Director, 10% Owner 0 2020-04-28 4,768,181    Premium*  
            Revolution Medicines, Inc. RVMD Director 2021-04-28 20,302 2021-04-28 3,145,258    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Rapt Therapeutics, Inc. RAPT Director, 10% Owner 2020-08-17 0 2020-09-22 5,630,497    Premium*  
* Premium Members only  

Records found :    116         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-03 3 IO $0.00 $0 I/I 0 475,957 -
ORIC Oric Pharmaceuticals, Inc... Director   –       •       •   2020-04-23 3 IO $0.00 $0 I/I 0 75,000 -
NRIX Nurix Therapeutics, Inc. 10% Owner   –       –       •   2020-07-23 3 IO $0.00 $0 D/D 0 83,333 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-08 4 B $13.98 $168 I/I 12 16,166,755 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-11 4 B $12.00 $180 I/I 15 16,420,829 2.17 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-25 4 B $18.00 $1,800 D/D 100 1,700,442 2.37 %
RVMD Revolution Medicines, Inc... Director   –       •      –    2021-04-28 4 AS $42.50 $4,250 I/I (100) 1,775,236 0 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-09 4 B $13.99 $2,126 I/I 152 16,166,907 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-06 4 B $13.96 $4,328 I/I 310 15,942,243 2.17 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-30 4 B $17.99 $13,169 D/D 732 1,617,684 2.37 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-02 4 B $13.97 $24,898 I/I 1,782 15,936,109 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-23 4 B $11.86 $24,752 I/I 2,087 16,412,405 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-22 4 B $12.00 $27,600 I/I 2,300 16,410,318 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-25 4 B $12.49 $30,176 I/I 2,416 17,205,077 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-01 4 B $13.98 $36,346 I/I 2,600 15,934,327 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-26 4 B $18.00 $67,518 I/I 3,751 16,469,480 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-21 4 B $14.03 $52,789 I/I 3,763 15,681,851 2.25 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-27 4 B $17.99 $68,974 D/D 3,834 1,612,847 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-16 4 B $13.86 $54,055 I/I 3,900 15,746,063 2.25 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-28 4 B $17.99 $73,849 D/D 4,105 1,616,952 2.45 %
CNST Constellation Pharmaceuti... Managing Partner   –       –       •   2020-03-20 4 B $23.15 $128,228 D/D 5,539 6,051,376 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-05 4 B $13.98 $81,400 I/I 5,824 15,941,933 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-19 4 B $13.99 $87,043 I/I 6,222 15,752,285 2.25 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-17 4 B $17.89 $114,943 D/D 6,425 1,681,997 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-17 4 B $10.62 $72,407 I/I 6,818 16,329,897 2.25 -
  116  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us